Amifostine in Treating Patients With Myelodysplastic Syndrome
Status:
Completed
Trial end date:
2001-02-12
Target enrollment:
Participant gender:
Summary
RATIONALE: Amifostine may improve blood counts in patients with myelodysplastic syndrome.
PURPOSE: Phase II trial to study the effectiveness of amifostine in treating patients with
myelodysplastic syndrome.